Top

Published in:

Open Access 01-01-2022 | Type 2 Diabetes | Review

Interpreting global trends in type 2 diabetes complications and mortality

Authors: Mohammed K. Ali, Jonathan Pearson-Stuttard, Elizabeth Selvin, Edward W. Gregg

Published in: Diabetologia | Issue 1/2022

Abstract

International trends in traditional diabetes complications (cardiovascular, renal, peripheral vascular, ophthalmic, hepatic or neurological diseases) and mortality rates are poorly characterised. An earlier review of studies published up to 2015 demonstrated that most data come from a dozen high-income countries (HICs) in North America, Europe or the Asia–Pacific region and that, in these countries at least, rates of acute glycaemic fluctuations needing medical attention and amputations, myocardial infarction and mortality were all declining over the period. Here, we provide an updated review of published literature on trends in type 2 diabetes complications and mortality in adults since 2015. We also discuss issues related to data collection, analysis and reporting that have influenced global trends in type 2 diabetes and its complications. We found that most data on trends in type 2 diabetes, its complications and mortality come from a small number of HICs with comprehensive surveillance systems, though at least some low- and middle-income countries (LMICs) from Africa and Latin America are represented in this review. The published data suggest that HICs have experienced declines in cardiovascular complication rates and all-cause mortality in people with diabetes. In parallel, cardiovascular complications and mortality rates in people with diabetes have increased over time in LMICs. However, caution is warranted in interpreting trends from LMICs due to extremely sparse data or data that are not comparable across countries. We noted that approaches to case ascertainment and definitions of complications and mortality (numerators) and type 2 diabetes (the denominator) vary widely and influence the interpretation of international data. We offer four key recommendations to more rigorously document trends in rates of type 2 diabetes complications and mortality, over time and worldwide: (1) increasing investments in data collection systems; (2) standardising case definitions and approaches to ascertainment; (3) strengthening analytical capacity; and (4) developing and implementing structured guidelines for reporting of data.

Graphical abstract

International Diabetes Federation (2019) IDF Diabetes Atlas 9th Edition. Available from https://www.diabetesatlas.org/en/. Accessed Feb 15 2020

NCD Risk Factor Collaboration (2016) Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387(10027):1513–1530. https://doi.org/10.1016/S0140-6736(16)00618-8CrossRef

Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW (2019) Global trends in diabetes complications: a review of current evidence. Diabetologia 62(1):3–16. https://doi.org/10.1007/s00125-018-4711-2CrossRefPubMed

NCD Countdown Collaborators (2018) NCD countdown 2030: worldwide trends in non-communicable disease mortality and progress towards sustainable development goal target 3.4. Lancet 392(10152):1072–1088. https://doi.org/10.1016/s0140-6736(18)31992-5CrossRef

Lin X, Xu Y, Pan X et al (2020) Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep 10(1):14790. https://doi.org/10.1038/s41598-020-71908-9CrossRefPubMedPubMedCentral

Ling W, Huang Y, Huang YM, Fan RR, Sui Y, Zhao HL (2020) Global trend of diabetes mortality attributed to vascular complications, 2000-2016. Cardiovasc Diabetol 19(1):182. https://doi.org/10.1186/s12933-020-01159-5CrossRefPubMedPubMedCentral

Zaccardi F, Dhalwani NN, Webb DR, Davies MJ, Khunti K (2018) Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates. Diabetologia 61(7):1592–1602. https://doi.org/10.1007/s00125-018-4626-yCrossRefPubMedPubMedCentral

Malhão TA, Brito Ados S, Pinheiro RS, Cabral Cda S, Camargo TM, Coeli CM (2016) Sex differences in diabetes mellitus mortality trends in Brazil, 1980-2012. PLoS One 11(6):e0155996. https://doi.org/10.1371/journal.pone.0155996CrossRefPubMedPubMedCentral

Nojilana B, Bradshaw D, Pillay-van Wyk V et al (2016) Emerging trends in non-communicable disease mortality in South Africa, 1997 - 2010. S Afr Med J 106(5):58. https://doi.org/10.7196/SAMJ.2016.v106i5.10674CrossRefPubMed

10.

Sarfo-Kantanka O, Sarfo FS, Oparebea Ansah E, Eghan B, Ayisi-Boateng NK, Acheamfour-Akowuah E (2016) Secular trends in admissions and mortality rates from diabetes mellitus in the Central Belt of Ghana: a 31-year review. PLoS One 11(11):e0165905. https://doi.org/10.1371/journal.pone.0165905CrossRefPubMedPubMedCentral

11.

Gregg EW, Cheng YJ, Srinivasan M et al (2018) Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet 391(10138):2430–2440. https://doi.org/10.1016/s0140-6736(18)30314-3CrossRefPubMed

12.

Wu H, Lau ESH, Ma RCW et al (2020) Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001-2016: a retrospective cohort study. Diabetologia 63(4):757–766. https://doi.org/10.1007/s00125-019-05074-7CrossRefPubMed

13.

Pearson-Stuttard J, Bennett J, Cheng YJ et al (2021) Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records. Lancet Diabetes Endocrinol 9(3):165–173. https://doi.org/10.1016/s2213-8587(20)30431-9CrossRefPubMedPubMedCentral

14.

Sacre JW, Harding JL, Shaw JE, Magliano DJ (2021) Declining mortality in older people with type 2 diabetes masks rising excess risks at younger ages: a population-based study of all-cause and cause-specific mortality over 13 years. Int J Epidemiol 50(4):1362–1372. https://doi.org/10.1093/ije/dyaa270CrossRefPubMed

15.

Lanting LC, Joung IMA, Mackenbach JP, Lamberts SWJ, Bootsma AH (2005) Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review. Diabetes Care 28(9):2280–2288. https://doi.org/10.2337/diacare.28.9.2280CrossRefPubMed

16.

Yu D, Zhao Z, Osuagwu UL et al (2021) Ethnic differences in mortality and hospital admission rates between Māori, Pacific, and European new Zealanders with type 2 diabetes between 1994 and 2018: a retrospective, population-based, longitudinal cohort study. Lancet Glob Health 9(2):e209–e217. https://doi.org/10.1016/S2214-109X(20)30412-5CrossRefPubMed

17.

Centers for Disease Control and Prevention (2017) Native Americans with Diabetes. Available from https://www.cdc.gov/vitalsigns/aian-diabetes/index.html. Accessed July 2021

18.

Gregg EW, Li Y, Wang J et al (2014) Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med 370(16):1514–1523. https://doi.org/10.1056/NEJMoa1310799CrossRefPubMed

19.

Harding JL, Benoit SR, Gregg EW, Pavkov ME, Perreault L (2020) Trends in rates of infections requiring hospitalization among adults with versus without diabetes in the U.S., 2000-2015. Diabetes Care 43(1):106–116. https://doi.org/10.2337/dc19-0653CrossRefPubMed

20.

Pearson-Stuttard J, Zhou B, Kontis V, Bentham J, Gunter MJ, Ezzati M (2018) Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment. Lancet Diabetes Endocrinol 6(6):e6–e15. https://doi.org/10.1016/S2213-8587(18)30150-5CrossRefPubMedPubMedCentral

21.

Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW (2013) Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med 368(17):1613–1624. https://doi.org/10.1056/NEJMsa1213829CrossRefPubMed

22.

Fang M, Wang D, Coresh J, Selvin E (2021) Trends in diabetes treatment and control in U.S. adults, 1999-2018. N Engl J Med 384(23):2219–2228. https://doi.org/10.1056/NEJMsa2032271CrossRefPubMed

23.

Flood D, Seiglie JA, Dunn M et al (2021) The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680,102 adults. Lancet Healthy Longevity 2(6):e340–e351. https://doi.org/10.1016/S2666-7568(21)00089-1CrossRef

24.

Manne-Goehler J, Geldsetzer P, Agoudavi K et al (2019) Health system performance for people with diabetes in 28 low- and middle-income countries: a cross-sectional study of nationally representative surveys. PLoS Med 16(3):e1002751. https://doi.org/10.1371/journal.pmed.1002751CrossRefPubMedPubMedCentral

25.

The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20(7):1183–1197. https://doi.org/10.2337/diacare.20.7.1183CrossRef

26.

The International Expert Committee (2009) International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32(7):1327–1334. https://doi.org/10.2337/dc09-9033CrossRefPubMedCentral

27.

American Diabetes Association (2010) Standards of medical Care in Diabetes—2010. Diabetes Care 33(Supplement 1):S11–S61. https://doi.org/10.2337/dc10-S011CrossRefPubMedCentral

28.

Selvin E, Wang D, Matsushita K, Grams ME, Coresh J (2018) Prognostic implications of single-sample confirmatory testing for undiagnosed diabetes: a prospective cohort study. Ann Intern Med 169(3):156–164. https://doi.org/10.7326/m18-0091CrossRefPubMedPubMedCentral

29.

Beagley J, Guariguata L, Weil C, Motala AA (2014) Global estimates of undiagnosed diabetes in adults. Diabetes Res Clin Pract 103(2):150–160. https://doi.org/10.1016/j.diabres.2013.11.001CrossRefPubMed

30.

Selvin E, Wang D, Lee AK, Bergenstal RM, Coresh J (2017) Identifying trends in undiagnosed diabetes in U.S. adults by using a confirmatory definition: a cross-sectional study. Ann Intern Med 167(11):769–776. https://doi.org/10.7326/m17-1272CrossRefPubMedPubMedCentral

31.

Alegre-Diaz J, Herrington W, Lopez-Cervantes M et al (2016) Diabetes and cause-specific mortality in Mexico City. N Engl J Med 375(20):1961–1971. https://doi.org/10.1056/NEJMoa1605368CrossRefPubMedPubMedCentral

32.

Anjana RM, Deepa M, Subashini R et al (2021) Temporal changes in diabetes prevalence and achievement of care goals in urban South Asia from 2010 to 2016 - the Center for Cardio-metabolic Risk Reduction in South Asia study. Diabet Med 38(2):e14424. https://doi.org/10.1111/dme.14424CrossRefPubMed

33.

Selvin E, Crainiceanu CM, Brancati FL, Coresh J (2007) Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 167(14):1545–1551. https://doi.org/10.1001/archinte.167.14.1545CrossRefPubMed

34.

Stone MA, Charpentier G, Doggen K et al (2013) Quality of care of people with type 2 diabetes in eight European countries: findings from the guideline adherence to enhance care (GUIDANCE) study. Diabetes Care 36(9):2628–2638. https://doi.org/10.2337/dc12-1759CrossRefPubMedPubMedCentral

35.

Shin JI, Wang D, Fernandes G et al (2021) Trends in receipt of American Diabetes Association guideline-recommended care among U.S. adults with diabetes: NHANES 2005-2018. Diabetes Care 44(6):1300–1308. https://doi.org/10.2337/dc20-2541CrossRefPubMed

36.

Danaei G, Finucane MM, Lin JK et al (2011) National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 377(9765):568–577. https://doi.org/10.1016/S0140-6736(10)62036-3CrossRefPubMed

37.

Farzadfar F, Finucane MM, Danaei G et al (2011) National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet 377(9765):578–586. https://doi.org/10.1016/S0140-6736(10)62038-7CrossRefPubMed

38.

Ali MK, Bullard KM, Saydah S, Imperatore G, Gregg EW (2018) Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014. Lancet Diabetes Endocrinol 6(5):392–403. https://doi.org/10.1016/S2213-8587(18)30027-5CrossRefPubMedPubMedCentral

39.

UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet (London, England) 352(9131):837–853CrossRef

40.

Ponto KA, Koenig J, Peto T et al (2016) Prevalence of diabetic retinopathy in screening-detected diabetes mellitus: results from the Gutenberg health study (GHS). Diabetologia 59(9):1913–1919. https://doi.org/10.1007/s00125-016-4013-5CrossRefPubMed

41.

Gedebjerg A, Almdal TP, Berencsi K et al (2018) Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: a cross-sectional baseline study of 6958 patients in the Danish DD2 cohort. J Diabetes Complicat 32(1):34–40. https://doi.org/10.1016/j.jdiacomp.2017.09.010CrossRef

42.

Lee KM, Sum WM (2011) Prevalence of diabetic retinopathy in patients with recently diagnosed diabetes mellitus. Clin Exp Optom 94(4):371–375. https://doi.org/10.1111/j.1444-0938.2010.00574.xCrossRefPubMed

43.

Fang M, Selvin E (2021) Thirty-year trends in complications in U.S. adults with newly diagnosed type 2 diabetes. Diabetes Care 44(3):699–706. https://doi.org/10.2337/dc20-2304CrossRefPubMed

44.

Hashimoto RE, Brodt ED, Skelly AC, Dettori JR (2014) Administrative database studies: goldmine or goose chase? Evid Based Spine Care J 5(2):74–76. https://doi.org/10.1055/s-0034-1390027CrossRefPubMedPubMedCentral

45.

Leong A, Dasgupta K, Bernatsky S, Lacaille D, Avina-Zubieta A, Rahme E (2013) Systematic review and meta-analysis of validation studies on a diabetes case definition from health administrative records. PLoS One 8(10):e75256. https://doi.org/10.1371/journal.pone.0075256CrossRefPubMedPubMedCentral

46.

Saeedi P, Salpea P, Karuranga S et al (2020) Mortality attributable to diabetes in 20–79 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract 108086. https://doi.org/10.1016/j.diabres.2020.108086

47.

Gregg EW, Zhuo X, Cheng YJ, Albright AL, Narayan KMV, Thompson TJ (2014) Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985–2011: a modelling study. Lancet Diabetes Endocrinol 2(11):867–874. https://doi.org/10.1016/S2213-8587(14)70161-5CrossRefPubMed

48.

Muschik D, Tetzlaff J, Lange K, Epping J, Eberhard S, Geyer S (2017) Change in life expectancy with type 2 diabetes: a study using claims data from lower Saxony, Germany. Popul Health Metrics 15(1):5. https://doi.org/10.1186/s12963-017-0124-6CrossRef

49.

Bardenheier BH, Lin J, Zhuo X et al (2016) Disability-free life-years lost among adults aged >/=50 years with and without diabetes. Diabetes Care 39(7):1222–1229. https://doi.org/10.2337/dc15-1095CrossRefPubMed

50.

Aschner P, Basit A, Fawwad A et al (2021) IDF Guide for Diabetes Epidemiology Studies. Available from https://idf.org/our-activities/epidemiology-research/idf-guide-for-diabetes-epidemiology-studies.html. Accessed 30 June 2021

51.

Cai M, Xie Y, Bowe B et al (2021) Temporal trends in incidence rates of lower extremity amputation and associated risk factors among patients using veterans health administration services from 2008 to 2018. JAMA Netw Open 4(1):e2033953. https://doi.org/10.1001/jamanetworkopen.2020.33953CrossRefPubMedPubMedCentral

52.

An J, Nichols GA, Qian L et al (2021) Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes. BMJ Open Diabetes Res Care 9(1):e001847. https://doi.org/10.1136/bmjdrc-2020-001847CrossRefPubMedPubMedCentral

53.

López-de-Andrés A, Albaladejo-Vicente R, Palacios-Ceña D et al (2020) Time trends in Spain from 2001 to 2018 in the incidence and outcomes of hospitalization for urinary tract infections in patients with type 2 diabetes mellitus. Int J Environ Res Public Health 17(24):9427. https://doi.org/10.3390/ijerph17249427CrossRefPubMedCentral

54.

Orozco-Beltrán D, Guillen-Mollá A, Cebrián-Cuenca AM et al (2021) Hospital admissions trends for severe hypoglycemia in diabetes patients in Spain, 2005 to 2015. Diabetes Res Clin Pract 171:108565. https://doi.org/10.1016/j.diabres.2020.108565CrossRefPubMed

55.

Ramalho A, Lobo M, Duarte L, Souza J, Santos P, Freitas A (2020) Landscapes on prevention quality indicators: a spatial analysis of diabetes preventable hospitalizations in Portugal (2016-2017). Int J Environ Res Public Health 17(22):8387. https://doi.org/10.3390/ijerph17228387CrossRefPubMedCentral

56.

Park JH, Ha KH, Kim BY, Lee JH, Kim DJ (2021) Trends in cardiovascular complications and mortality among patients with diabetes in South Korea. Diabetes Metab J 45(1):120–124. https://doi.org/10.4093/dmj.2020.0175CrossRefPubMed

57.

You JH, Song SO, Park SH et al (2019) Trends in hyperglycemic crisis hospitalizations and in- and out-of-hospital mortality in the last decade based on Korean National Health Insurance Claims Data. Endocrinol Metab (Seoul) 34(3):275–281. https://doi.org/10.3803/EnM.2019.34.3.275CrossRef

58.

Kim J, Chun DI, Kim S et al (2019) Trends in lower limb amputation in patients with diabetic foot based on vascular intervention of peripheral arterial disease in Korea: a population-based Nationwide study. J Korean Med Sci 34(26):e178. https://doi.org/10.3346/jkms.2019.34.e178CrossRefPubMedPubMedCentral

59.

Wu H, Yang A, Lau ESH et al (2020) Secular trends in rates of hospitalisation for lower extremity amputation and 1 year mortality in people with diabetes in Hong Kong, 2001-2016: a retrospective cohort study. Diabetologia 63(12):2689–2698. https://doi.org/10.1007/s00125-020-05278-2CrossRefPubMed

60.

Lin CW, Armstrong DG, Lin CH et al (2019) Nationwide trends in the epidemiology of diabetic foot complications and lower-extremity amputation over an 8-year period. BMJ Open Diabetes Res Care 7(1):e000795. https://doi.org/10.1136/bmjdrc-2019-000795CrossRefPubMedPubMedCentral

61.

Florêncio RB, de Araújo Fonseca LG, da Silva VFD, Lima ÍNDF, Gualdi LP (2021) Diabetes mellitus hospitalization and mortality rate according to a national database in Brazil: a longitudinal study. BMC Public Health 21(1):403. https://doi.org/10.1186/s12889-021-10438-zCrossRefPubMed

62.

Klafke A, Duncan BB, Stevens A et al (2015) The decline in mortality due to acute complications of diabetes mellitus in Brazil, 1991-2010. BMC Public Health 15:772. https://doi.org/10.1186/s12889-015-2123-5CrossRefPubMedPubMedCentral

63.

Chaparro-Narváez P, Alvis-Zakzuk NJ, Díaz-Jiménez D, Castañeda-Orjuela C (2021) Trends in diabetes mortality identified from death certificates in Colombia, 1979-2017. Rev Panam Salud Publica 45:e13. https://doi.org/10.26633/rpsp.2021.13CrossRefPubMed

64.

Hernández H, Macías G (2017) Time-trend analysis of diabetes mellitus mortality in Argentina, 1990-2013. Rev Panam Salud Publica 41:e73. https://doi.org/10.26633/rpsp.2017.73CrossRefPubMedPubMedCentral

65.

Li Y, Kou C, Bai W et al (2019) Trends in diabetes mortality by gender in urban and rural areas in China from 2003 to 2012: An age-period-cohort analysis. Asia Pac J Public Health 31(3):238–245. https://doi.org/10.1177/1010539519841288CrossRefPubMed

66.

Li HY, Wu YL, Tu ST, Hwu CM, Liu JS, Chuang LM (2019) Trends of mortality in diabetic patients in Taiwan: a nationwide survey in 2005-2014. J Formos Med Assoc 118(Suppl 2):S83–s89. https://doi.org/10.1016/j.jfma.2019.07.008CrossRefPubMed

Title: Interpreting global trends in type 2 diabetes complications and mortality
Authors: Mohammed K. Ali
Jonathan Pearson-Stuttard
Elizabeth Selvin
Edward W. Gregg
Publication date: 01-01-2022
Publisher: Springer Berlin Heidelberg
Keyword: Type 2 Diabetes
Published in: Diabetologia / Issue 1/2022
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-021-05585-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Graphical abstract

Please log in to get access to this content

Other articles of this Issue 1/2022

Correction to: The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants

Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary events

Lipotoxicity-induced circGlis3 impairs beta cell function and is transmitted by exosomes to promote islet endothelial cell dysfunction

Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study

IAPP-induced beta cell stress recapitulates the islet transcriptome in type 2 diabetes

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage